Original paper

Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study

Volume: 35, Issue: 36, Pages: 4050 - 4056
Published: Aug 24, 2017
Paper Details
Title
Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1–Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study
Published Date
Aug 24, 2017
Volume
35
Issue
36
Pages
4050 - 4056
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
© 2025 Pluto Labs All rights reserved.